Aeglea Biotherapeutics, Inc. (AGLE) Files Form 4 Insider Buying : Eli & Co Lilly Buys 500,000 Shares

Aeglea Biotherapeutics, Inc. (AGLE): Eli & Co Lilly , 10% owner of Aeglea Biotherapeutics, Inc. purchased 500,000 shares on Apr 12, 2016. The Insider buying transaction was reported by the company on Apr 14, 2016 to the Securities and Exchange Commission. The shares were purchased at $10.00 per share for a total value of $5,000,000.00 according the SEC Form 4 Filing.

Leave a Reply

Aeglea Biotherapeutics, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Aeglea Biotherapeutics, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.